Oxidation chemistry of norepinephrine: Partitioning of the O-quinone between competing cyclization and chain breakdown pathways and their roles in melanin formation

Chemical Research in Toxicology

Volumn 20, Issue 10, 2007, Pages 1549-1555

  Manini, Paola ^a   Panzella, Lucia ^a   Napolitano, Alessandra ^a   D'Ischia, Marco ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYMANDELIC ACID; 3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; ADRENOCHROME; CATECHOLAMINE; DICARBOXYLIC ACID DERIVATIVE; EUMELANIN; HORSERADISH PEROXIDASE; HYDROGEN PEROXIDE; INDOLE DERIVATIVE; MELANIN; NORADRENALIN; PROTOCATECHUALDEHYDE; PROTOCATECHUIC ACID; QUINONE DERIVATIVE; REAGENT; TRICARBOXYLIC ACID;

ARTICLE; CHEMISTRY; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CYCLIZATION; DEGENERATIVE DISEASE; LOCUS CERULEUS; POLYMERIZATION; PROTEIN FUNCTION;

BENZOQUINONES; CYCLIZATION; HORSERADISH PEROXIDASE; HYDROGEN PEROXIDE; INDOLEQUINONES; INDOLES; IRON; MELANINS; NOREPINEPHRINE; OXIDANTS; OXIDATION-REDUCTION;

ARMORACIA RUSTICANA;

EID: 35848969108     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx700254q     Document Type: Article

References (42)

1. Kalinin, S., Gavrilyuk, V., Polak, P. E., Heneka, M. T., and Feinstein, D. L. (2007) Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease. Neurobiol. Aging 28, 1206-1214.
2. Srinivasan, J., and Schmidt, W. J. (2003) Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine- induced partial degeneration of substantia nigra in rats. Eur. J. Neurosci. 17, 2586-2592.
3. Gesi, M., Soldani, P., Giorgi, F. S., Santinami, A., Bonaccorsi, I., and Fornai, F. (2000) The role of the locus coeruleus in the development of Parkinson's disease. Neurosci. Biobehav. Rev. 24, 655-668.
4. Zucca, F. A., Bellei, C., Giannelli, S., Terreni, M. R., Gallorini, M., Rizzio, E., Pezzoli, G., Albertini, A., and Zecca, L. (2006) Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability. J. Neural Transm. 113, 757-767.
5. Szot, P., White, S. S., Greenup, J. L., Leverenz, J. B., Peskind, E. R., and Raskind, M. A. (2006) Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies. J. Neurosci. 26, 467-478.
6. Shen, X-M., and Dryhurst, G. (1996) Oxidation chemistry of (-)norepinephrine in the presence of L-cysteine. J. Med. Chem. 39, 2018-2029.
7. Xin, W., Shen, X-M., Li, H., and Dryhurst, G. (2000) Oxidative metabolites of 5-S-cysteinylnorepinephrine are irreversible inhibitors of mitochondrial complex I and α-ketoglutarate dehydrogenase and pyruvate dehydrogenase complexes: possible implications for neurodegenerative brain disorders. Chem. Res. Toxicol. 13, 749-760.
8. Dell'Anna, M. L., and Picardo, M. (2006) A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo. Pigm. Cell Res. 19, 406-411.
9. 2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J. Invest. Dermatol. 4, 91-96.
10. Cucchi, M. L., Frattini, P., Santagostino, G., and Orecchia, G. (2000) Higher plasma catecholamine and metabolite levels in the early phase of non-segmental vitiligo. Pigm. Cell Res. 13, 28-32.
11. Cucchi, M. L., Frattini, P., Santagostino, G., Preda, S., and Orecchia, G. (2003) Catecholamines increase in the urine of non-segmental vitiligo especially during its active phase. Pigm. Cell Res. 16, 111-116.
12. Solano, F., Hearing, V. J., and Garcia-Borron, J. C. (2000) Neurotoxicity due to o-quinones: neuromelanin formation and possible mechanisms for o-quinone detoxification. Neurotox. Res. 1, 153-169.
13. Terland, O., Almas, B., Flatmark, T., Andersson, K. K., and Sorlie, M. (2006) One-electron oxidation of catecholamines generates free radicals with an in vitro toxicity correlating with their lifetime. Free Radical Biol. Med. 41, 1266-1271.
14. Jimenez, M., Garcia-Canovas, F., Garcia-Carmona, F., Lozano, J.A., and Iborra, J.L. (1984) Kinetic study and intermediates identification of noradrenaline oxidation by tyrosinase. Biochem. Pharmacol. 33, 3689-3697.
15. Bouchilloux, S., and Kodja, A. (1958) The characterization and isolation by chromatography and paper electrophoresis of substances observed in melanogenesis in vitro. Compt. Rend. 247, 2484-2486.
16. Giulivi, C., and Cadenas, E. (1998) Oxidation of adrenaline by ferrylmyoglobin. Free Radical Biol. Med. 25, 175-183.
17. Manini, P., Pezzella, A., Panzella, L., Napolitano, A., and d'Ischia, M. (2005) New insight into the oxidative chemistry of noradrenaline: competitive o-quinone cyclisation and chain fission routes leading to an unusual 4-[bis-(1H-5,6-dihydroxyindol-2-yl)methyl]-1,2-dihydroxybenzene derivative. Tetrahedron 61, 4075-4080.
18. Remião, F., Milhazes, N., Borges, F., Carvalho, F., Bastos, M., Lemos-Amado, F., Domingues, P., and Ferrer-Correia, A. (2003) Synthesis and analysis of aminochromes by HPLC-photodiode array. Adrenochrome evaluation in rat blood. Biomed. Chromatogr. 17, 6-13.
19. Benigni, J. D., and Minnis, R. L. (1965) The syntheses of 5,6-dihydroxyindole and some of its derivatives. J. Heterocycl. Chem. 2, 387-392.
20. Napolitano, A., Pezzella, A., Vincensi, M. R., and Prota, G. (1995) Oxidative degradation of melanins to pyrrole acids: a model study. Tetrahedron 51, 5913-5920.
21. Sugumaran, M., Dalit, H., and Semensi, V. (1992) Mechanistic studies on tyrosinase-catalysed oxidative decarboxylation of 3,4-dihydroxymandelic acid. Biochem. J. 281, 353-357.
22. +-induced neurotoxicity in PC12 cells. Food Chem. Toxicol. 44, 436-443.
23. Napolitano, A., Pezzella, A., d'Ischia, M., and Prota, G. (1996) New pyrrole acids by oxidative degradation of eumelanins with hydrogen peroxide. Further hints to the mechanism of pigment breakdown. Tetrahedron 52, 8775-8780.
24. Ito, S., and Fujita, K. (1985) Microanalysis of eumelanin and pheomelanin in hair and melanomas by chemical degradation and liquid chromatography. Anal. Biochem. 144, 527-536.
25. Martinez Ortiz, F., Tutela Serrano, J., Rodriguez Lopez, J. N., Varon Castellanos, R., Lozano Teruel, J. A., and Garcia-Canovas, F. (1988) Oxidation of 3,4-dihydroxymandelic acid catalyzed by tyrosinase. Biochim. Biophys. Acta 957, 158-163.
26. Sugumaran, M. (1986) Tyrosinase catalyzes an unusual oxidative decarboxylation of 3,4-dihydroxymandelate. Biochemistry 25, 4489-4492.
27. Ito, S., and Wakamatsu, K. (1998) Chemical degradation of melanins: application to identification of dopamine-melanin. Pigm. Cell Res. 11, 120-126.
28. Chavdarian, C. G., Karashima, D., and Castagnoli, N., Jr. (1978) Oxidative and cardiovascular studies on natural and synthetic catecholamines. J. Med. Chem. 21, 548-554.
29. Tribl, F., Marcus, K., Meyer, H. E., Bringmann, G., Gerlach, M., and Riederer, P. (2006) Subcellular proteomics reveals neuromelanin granules to be a lysosome-related organelle. J. Neural Transm. 113, 741-749.
30. 2+ complexes with model neuromelanins. Appl. Magn. Res. 24, 417-422.
31. Hasking, G. J., and Esler, M. D. (1990) Plasma norepinephrine and treatment of heart failure. Am. J. Cardiol. 66, 386-387.
32. Esler, M., and Kaye, D. (2000) Measurement of sympathetic nervous system activity in heart failure: the role of norepinephrine kinetics. Heart Failure Rev. 5, 17-25.
33. Tseng, T. H., Tsheng, Y. M., and Lee, Y. J. (2001) Cytotoxicity effects of di- and tri-hydroxybenzaldehydes as a chemopreventive potential agent on tumor cells. Toxicology 161, 179-187.
34. Nishimura, M., Umeda, M., Kusanagi, A., Urakabe, R., Yukimatsu, K., and Otawara, S. (1981) Antiproliferative activity of protocatechualdehyde on Chinese hamster cells grown in culture. Gann. 72, 868-879.
35. Nishimura, M., Umeda, M., Kusanagi, A., Urakabe, R., Yukimatsu, K., and Otawara, S. (1981) Cytomorphological study of cultured mammalian cells treated with benzaldehyde, catechol and their derivatives with special reference to inhibition of DNA synthesis. Gann. 72, 272-279.
36. Youdim, M. B. H., Double, K. L., Gerlach, M., and Riederer, P. (2006) Neuromelanin. J. Neural Transm. 113, 63.
37. Shamoto-Nagai, M., Maruyama, W., Yi, H., Akao, Y., Tribl, F., Gerlach, M., Osawa, T., Riederer, P., and Naoi, M. (2006) Neuromelanin induces oxidative stress in mitochondria through release of iron: mechanism behind the inhibition of 26S proteasome. J. Neural Transm. 113, 633-644.
38. Goetz, M. E., Double, K., Gerlach, M., Youdim, M. B. H., and Riederer, P. (2004) The relevance of iron in the pathogenesis of Parkinson's disease. Ann. N.Y. Acad. Sci. 1012, 193-208.
39. Enochs, W. S., Sarna, T., Zecca, L., Riley, P. A., and Swartz, H. M. (1994) The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis. J. Neural Transm. 7, 83-100.
40. Zecca, L., Shima, T., Stroppolo, A., Goj, C., Battiston, G. A., Gerbasi, R., Sarna, T., and Swartz, H. M. (1996) Interaction of neuromelanin and iron in substantia nigra and other areas of human brain. Neurosci. 73, 407-415.
41. Fasano, M., Bergamasco, B., and Lopiano, L. (2006) Modifications of the iron-neuromelanin system in Parkinson's disease. J. Neurochem. 96, 909-916.
42. Rajan, K. S., and Davis, J. M. (1976) Interactions of iron with biogenic amines and ATP. J. Inorg. Nucl. Chem. 38, 897-905.